Recherche
Enseignement
S'identifier
FR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
Program in Developmental Therapeutics
Elizabeth A. Hopper-Borge has not added Biography.
If you are Elizabeth A. Hopper-Borge and would like to personalize this page please email our Author Liaison for assistance.
Mechanisms of tumor resistance to EGFR-targeted therapies.
Expert opinion on therapeutic targets Mar, 2009 | Pubmed ID: 19236156
Chemotherapy and signaling: How can targeted therapies supercharge cytotoxic agents?
Cancer biology & therapy Nov, 2010 | Pubmed ID: 20935499
Contribution of Abcc10 (Mrp7) to in vivo paclitaxel resistance as assessed in Abcc10(-/-) mice.
Cancer research May, 2011 | Pubmed ID: 21576088
Modulation of the ATPase and transport activities of broad-acting multidrug resistance factor ABCC10 (MRP7).
Cancer research Dec, 2012 | Pubmed ID: 23087055
Fox Chase Cancer Center
Joely D. Jacobs1,
Elizabeth A. Hopper-Borge1
1Program in Developmental Therapeutics, Fox Chase Cancer Center
Confidentialité
Conditions d'utilisation
Politiques
Contactez-nous
RECOMMANDER À LA BIBLIOTHÈQUE
NEWSLETTERS JoVE
Journal JoVE
Collections de méthodes
Encyclopédie des expériences JoVE
Archives
JoVE Core
JoVE Science Education
Manuel de laboratoire JoVE
Centre de ressources universitaires
Auteurs
Vue d'ensemble
Processus de publication
Comité éditorial
Domaines et politique de publication
Révision par les pairs
FAQ
Soumettre
Bibliothécaires
Témoignages
Abonnements
Accès
Ressources
Conseil consultatif des bibliothèques
À PROPOS DE JoVE
Direction
Copyright © 2024 MyJoVE Corporation. Tous droits réservés.